Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

Yusuke Inoue,Yuji Asano,Takefumi Satoh,Ken-ichi Tabata,Kei Kikuchi,Reiko Woodhams,Shiro Baba,Kazushige Hayakawa

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer

2014

Yusuke Inoue
Yuji Asano
Takefumi Satoh
Ken-ichi Tabata
Kei Kikuchi
Reiko Woodhams
Shiro Baba
Kazushige Hayakawa

Objective(s): We performed a phase IIa clinical trial of trans-1-amino-3-18F-fluoro-cyclobutane carboxylic acid (anti-18F-FACBC), a synthetic amino acid analog for PET, in patients with metastatic prostate cancer.

Keywords:

Clinical trial
Cyclobutane
Prostate cancer
Amino acid
Positron emission tomography
Metastasis
Carboxylic acid
Internal medicine
Medicine
Text mining
Oncology
Urology
Lymph node
Prostate
Lesion
Lymph
Bone metastasis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations